• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Biogen Idec Inc. (BIIB)

    -NasdaqGS
    360.67 Up 6.97(1.97%) 4:00PM EST
    |After Hours : 360.67 0.00 (0.00%) 4:54PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 6,932,199   5,516,461   5,048,634  
    Cost of Revenue857,726  545,494  466,780  
    Gross Profit 6,074,473   4,970,967   4,581,854  
    Operating Expenses
    Research Development1,444,053  1,334,919  1,219,602  
    Selling General and Administrative1,796,861  1,622,562  1,409,969  
    Non Recurring -  2,225  19,026  
    Others342,948  202,204  208,566  
    Total Operating Expenses -  3,161,910  2,857,163  
    Operating Income or Loss 2,515,509   1,855,849   1,724,691  
    Income from Continuing Operations
    Total Other Income/Expenses Net(10,032)46,048  (13,477)
    Earnings Before Interest And Taxes2,505,477  1,901,897  1,711,214  
    Interest Expense -   -   -  
    Income Before Tax2,505,477  1,901,897  1,711,214  
    Income Tax Expense601,014  470,554  444,528  
    Minority Interest -   -  (32,258)
    Net Income From Continuing Ops1,887,239  1,426,825  1,234,428  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 1,862,341   1,380,033   1,234,428  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 1,862,341   1,380,033   1,234,428  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.